Marshall Wace’s Tevogen Inc. Common Stock TVGN Stock Holding History

Marshall Wace’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,611	Closed	-$2.38M	–	3178
2022 Q4	$2.38M	Sell	4,611 -7,487	-62%	-$3.83M	0.01%	1632
2022 Q3	$6.15M	Buy	12,098 +4,000	+49%	+$2.02M	0.01%	1222
2022 Q2	$4.05M	Buy	8,098 +2,098	+35%	+$1.05M	0.01%	1498
2022 Q1	$3M	Buy	+6,000	New	+$2.98M	0.01%	1779

Other funds holding TVGN

CCP

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

FCM

FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's TVGN Position: Q1 2023 in Review

Marshall Wace sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 4,611 shares — an estimated $2.38M sold.

Marshall Wace first reported a position in TVGN in Q1 2022 and held it in 4 quarters. The position peaked at $6.15M in Q3 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

Marshall Wace reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Marshall Wace sold 4,611 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $2.38M.
Marshall Wace first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Marshall Wace's Tevogen Inc. Common Stock position peaked at $6.15M in Q3 2022.
4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.